Short interest in ALLE has declined 21% over the past month while analysts slash price targets. Borrowing costs have eased and utilisation sits near multi-week lows heading into the April 28 earnings call.
Short interest stands at 3.24 million shares as of April 23, representing 3.77% of the float. That's down 0.2% over the past week and down 21% over the past month. Days to cover sits at 3.36 based on recent volume. Cost to borrow has fallen to 0.38%, down 2% over the week and 24% over the month. Utilisation has dropped sharply to 3.78% from a 52-week high of 12.28%, suggesting ample shares available and minimal borrow stress. Short sellers appear to be reducing exposure ahead of the print.
The put/call ratio closed at 0.27 on April 24, well below the 20-day mean of 0.45. The z-score of -1.71 indicates a strong tilt toward call activity. The current PCR sits near the lower end of the 52-week range of 0.07 to 0.67. Options traders are leaning bullish heading into earnings.
Analyst coverage lacks a consensus rating in the snapshot, but the mean price target of $173.17 implies 18.5% upside from the current $146.10 close. Recent moves have been universally negative. B of A Securities cut its target to $157 from $185 on April 20 while maintaining Neutral. Barclays lowered to $165 from $176 on April 1, maintaining Equal-Weight. Wells Fargo dropped to $155 from $175, also Equal-Weight. JP Morgan trimmed to $180 from $190 in February, holding Overweight. Every firm-level change since October has been a price-target reduction, signaling waning Street confidence.
The P/E ratio stands at 16.3, down 0.1 points over the past month. EV/EBITDA sits at 13.0, up 0.1 points over 30 days. The P/B ratio of 4.60 has declined 0.08 points in the same window. On factor scores, ALLE ranks in the 93rd percentile on analyst recommendation differential, the 63rd percentile on EV/EBIT, and the 50th percentile on earnings yield. EPS momentum scores sit at the 41st percentile (30-day) and 40th percentile (90-day), indicating below-average earnings revision trends.
Insiders have been net buyers over the past 90 days, accumulating 10,915 shares worth approximately $1.74 million net. Director Susan Main purchased 2,000 shares in mid-March at prices near $149–$150. Multiple executives sold small blocks in late February following a stock price near $160. Vanguard remains the largest holder with 10.6 million shares (12.3%), adding 337,000 shares in Q1. BlackRock holds 6.6 million shares (7.7%), up 23,000. Boston Partners holds 4.6 million shares (5.4%).
ALLE most recently reported on April 24, 2026. Prior prints occurred in February 2026. The stock closed at $146.10 on April 24, down 0.9% on the day but up 1.2% over the week. Shares are up 0.3% over the past month.
No active ORTEX Alpha signals are currently flagged for ALLE.
See the live data behind this article on ORTEX.
Open ALLE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
